The report provides a detailed analysis of the current acute respiratory distress syndrome (ARDS) marketed drugs and late-stage pipeline drugs. Inside the ARDS Market | How Tech, Awareness, Rising ...

Emerging Acute Respiratory Distress Syndrome therapies in the different phases of clinical trials are- RSBT-001, AVM0703, CYP 001, AV 001, ALT-100, STSA-1002, GEn-1124, Descartes 30, Rhu-pGSN ...

Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.

Researchers have found in a new study that Pleurodesis using talc or minocycline had potential as a treatment option for ...

The R/I ratio showed limited accuracy in predicting lung recruitability in ARDS but reliably identified low recruiters.

This international study focuses on comparing two methods of administering surfactant, a liquid medicine, to prematurely born ...